Rigel Pharmaceuticals (RIGL) EPS (Basic) Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -100.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 61.11% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3,856.63% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.78% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,207.14% |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | -26.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.56% |
| Dec 31, 2025 | 1,737.04% |
| Sep 30, 2025 | 118.31% |
| Jun 30, 2025 | 5,650.00% |
| Mar 31, 2025 | 236.17% |
| Dec 31, 2024 | 1,520.00% |
| Sep 30, 2024 | 315.15% |
| Jun 30, 2024 | 84.21% |
| Mar 31, 2024 | -487.50% |
| Dec 31, 2023 | 101.62% |
| Sep 30, 2023 | -200.00% |
| Jun 30, 2023 | -375.00% |
| Mar 31, 2023 | 50.00% |
| Dec 31, 2022 | -2,107.14% |
| Sep 30, 2022 | 8.33% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | -169.57% |
| Dec 31, 2021 | -27.27% |
| Sep 30, 2021 | -50.00% |
| Jun 30, 2021 | 20.00% |
| Mar 31, 2021 | 76.92% |
| Dec 31, 2020 | -10.00% |
| Sep 30, 2020 | -14.29% |
| Jun 30, 2020 | 16.67% |
| Mar 31, 2020 | 218.18% |
| Dec 31, 2019 | -600.00% |
| Sep 30, 2019 | 50.00% |
| Jun 30, 2019 | 25.00% |
| Mar 31, 2019 | 35.29% |
| Dec 31, 2018 | 111.11% |
| Sep 30, 2018 | 0.00% |
| Jun 30, 2018 | 0.00% |
| Mar 31, 2018 | -30.77% |
| Dec 31, 2017 | -12.50% |
| Sep 30, 2017 | 41.67% |
| Jun 30, 2017 | -6.67% |
| Mar 31, 2017 | 31.58% |
| Dec 31, 2016 | -14.29% |
| Sep 30, 2016 | -200.00% |
| Jun 30, 2016 | 6.25% |
| Mar 31, 2016 | 9.52% |
| Dec 31, 2015 | 44.00% |
| Sep 30, 2015 | 66.67% |
| Jun 30, 2015 | 44.83% |
| Mar 31, 2015 | 16.00% |
| Dec 31, 2014 | -31.58% |
| Sep 30, 2014 | 11.11% |
| Jun 30, 2014 | -11.54% |
| Mar 31, 2014 | 13.79% |
| Dec 31, 2013 | 36.67% |
| Sep 30, 2013 | 25.00% |
| Jun 30, 2013 | 25.71% |
| Mar 31, 2013 | 9.38% |
| Dec 31, 2012 | 18.92% |
| Sep 30, 2012 | -44.00% |
| Jun 30, 2012 | 5.41% |
| Mar 31, 2012 | 20.00% |
| Dec 31, 2011 | -12.12% |
| Sep 30, 2011 | -125.77% |
| Jun 30, 2011 | -171.15% |